Dendritic cell activation
Dendritic cells are specialized antigen presenting cells (APCs) of the immune system that act as sentinels for detecting pathogens and danger signals.
In their immature state, they are highly efficient at antigen uptake but have limited capacity to stimulate T cells. Upon exposure to stimuli, such as microbial components or inflammatory cues, they undergo a coordinated activation process driven by pathways including Toll-like receptor signaling.
This results in functional reprogramming characterized by:
How dendritic cell activation assays work
In a typical assay, monocytes isolated from peripheral blood mononuclear cells (PBMCs) are differentiated into monocyte-derived dendritic cells (moDCs) using cytokines such as GM-CSF and IL-4. These cells are immature dendritic cells (iDCs) that provide a robust in vitro model for studying dendritic cell activation in response to various stimuli. Activation triggers intracellular signaling pathways that drive dendritic cell maturation and functional reprogramming, resulting in distinct morphological, phenotypic, and functional changes.
We assess these responses through a combination of:
Together, these readouts provide a comprehensive measure of dendritic cell activation and their capacity to initiate adaptive immune responses.
How to choose a dendritic cell activation assay
Selecting the appropriate assay depends on your research objectives and experimental requirements.
Essential factors include:
Additional factors such as assay sensitivity, throughput, and reproducibility should also be considered when designing your study.
Key DC activation assay considerations
Several factors influence the outcome and reliability of dendritic cell activation assays.
Our dendritic cell activation assay service
Our dendritic cell activation assay service delivers reliable, physiologically relevant data to support immunogenicity assessment, vaccine development, and preclinical research.
By combining advanced in vitro models with high-quality human biospecimens, we enable precise evaluation of dendritic cell activation and immune response potential.
Direct access to human biospecimens
As a sister company of BIOMEX, we have direct access to high-quality human biospecimens and a well-established global network of collection centers. This unique setup allows us to:
Scientifically robust assay design
Using monocyte-derived dedritic cells (moDCs) from human peripheral blood, we generate biologically relevant data that closely reflect in vivo immune responses. Our assay platform integrates multiple readouts to comprehensively assess dendritic cell activation and function.
What we support you with
We work closely with you to design and execute bioassays tailored to your specific research needs:
Contact us